
Massive Pharmaceuticals Private Limited - Loans (Charges)
Founded in 2006 and headquartered in Tamil Nadu, India.

Founded in 2006 and headquartered in Tamil Nadu, India.
Data last updated:
Massive Pharmaceuticals Private Limited has 7 charges registered with the Registrar of Companies: 5 open charges worth Rs 1.79 Cr and 2 satisfied charges worth Rs 1.00 Cr. The lender named on its open charges is Hdfc Bank Limited. The most recent charge was created on 19 Mar 2024 in favour of Hdfc Bank Limited for Rs 1.05 M and is open.
₹179.38 lakh
₹100.00 lakh
3
Others
Creation
19 Mar 2024
₹10.53 lakh
| Charge Id | Lender | Amount | Creation Date | Last Modification Date | Satisfaction Date | Status |
|---|---|---|---|---|---|---|
| 10355616 View Details | The Karur Vysya Bank Limited | ₹ 40.00 | 18 Apr 2012 | 25 Jun 2013 | 02 Aug 2016 | Satisfied |
| 10355627 View Details | The Karur Vysya Bank Limited | ₹ 60.00 | 18 Apr 2012 | 09 Sep 2015 | 02 Aug 2016 | Satisfied |
| 100912965 View Details | Hdfc Bank Limited | ₹ 10.53 | 19 Mar 2024 | - | - | Open |
| 100912974 View Details | Hdfc Bank Limited | ₹ 15.81 | 18 Mar 2024 | - | - | Open |
| 100433310 View Details | Hdfc Bank Limited | ₹ 11.26 | 30 Jan 2021 | - | - | Open |
| 100438463 View Details | Hdfc Bank Limited | ₹ 11.78 | 30 Jan 2021 | 09 Mar 2022 | - | Open |
| 100054265 View Details | Others | ₹ 130.00 | 02 Aug 2016 | 27 Jun 2020 | - | Open |
Premium access Charge documents and asset detailsThe filed charge documents and the assets pledged under each charge are in the company report.
Verified entity values are shown only after access is granted. | ||||||
A charge is a security interest a company creates over its assets in favour of a lender. An open charge is still outstanding; a satisfied charge has been repaid and closed with the Registrar. Under the Companies Act, 2013 every charge must be registered within thirty days of creation (Form CHG-1, or CHG-9 for debentures) and its satisfaction reported within thirty days of repayment (Form CHG-4). Amounts are as filed with the MCA.